Eloxx Pharmaceut (ELOX) Stock Price, News & Analysis
Company Description
Eloxx Pharmaceut (NASDAQ: ELOX) is classified in the biotechnology industry within the Biological Products, (no Diagnostic Substances) sector and carries a market capitalization of $41.0M, ranking #5,904 among all listed U.S. companies by market cap.
ELOX has gained 1100809.1% over the past year. Shares last traded at $12.11.
For FY2025, Eloxx Pharmaceut reported revenue of $0 with net income of -$6.0M and diluted earnings per share of $-5.34.
This page collects what Stock Titan holds for ELOX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Eloxx Pharmaceut (ELOX) stock last closed at $12.11. Over the past 12 months, the stock has gained 1100809.1%. At a market capitalization of $41.0M, ELOX is classified as a micro-cap stock with approximately 3.4M shares outstanding.
ELOX Rankings
Latest News
Eloxx Pharmaceut has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include offering, earnings, management, clinical trial. View all ELOX news →
SEC Filings
Eloxx Pharmaceut has filed 5 recent SEC filings, including 3 Form SCHEDULE 13G, 1 Form 3, 1 Form 4. The most recent filing was submitted on July 27, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ELOX SEC filings →
Financial Highlights
operating income reached -$6.4M, and net income was -$6.0M. Diluted earnings per share stood at $-5.34. The company generated -$6.3M in operating cash flow. With a current ratio of 0.31, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Eloxx Pharmaceut (ELOX) currently stands at 11.0 thousand shares, up 41.8% from the previous reporting period, representing 0.4% of the float. Since July 2025, short interest has increased by 434.6%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Eloxx Pharmaceut (ELOX) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 89.3% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
ELOX Company Profile & Sector Positioning
Eloxx Pharmaceut (ELOX) operates in the Biotechnology industry within the broader Biological Products, (no Diagnostic Substances) sector and is listed on the NASDAQ.
Investors comparing ELOX often look at related companies in the same sector, including Regenerx Biopharmaceuticals (RGRX), Neximmune, Inc. (NEXI), Effector Therapeutics Inc (EFTR), Gritstone Bio Inc (GRTSQ), and Innoveren Scientific Inc (IVRN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ELOX's relative position within its industry.